Литература
1. Витязева, И.И., Алташина М.В., Трошина Е.А. Влияние нарушений жирового обмена на фертильность мужчин репродуктивного возраста и эффективность программ ЭКО // Пробл. эндокринол. 2014. Т. 60, № 5. С. 34-42.
2. Всемирная организация здравоохранения (ВОЗ). Информационный бюллетень: Ожирение и избыточный вес. 18 октября 2017 г. URL: http://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight.
3. Долгушина Н.В., Десяткова Н.В., Коротченко О.Е. и др. Влияние избыточной массы тела и ожирения на развитие анеуплоидии эмбрионов и исходы программ вспомогательных репродуктивных технологий // Пробл. репродукции. 2017. Т. 23, № 1. С. 48- 53.
4. Колода Ю.А. Особенности программ вспомогательных репродуктивных технологий у пациенток с избыточной массой тела и ожирением : дис. ... канд. мед. наук. М., 2010. 117 с.
5. Междисциплинарная ассоциация специалистов репродуктивной медицины (МАРС). Прегравидарная подготовка. Клинический протокол для специалистов в области репродуктивной медицины. М. : StatusPraesens, 2016. 86 с.
6. Махмадалиева М.Р., Коган И.Ю., Ниаури Д.А. и др. Влияние избытка массы тела и ожирения на эффективность программ вспомогательных репродуктивных технологий // Журн. акуш. и жен. бол. 2018. Т. 67, № 2. С. 32-39. doi: 10.17816/JOWD67232-39.
7. Alahmar А.Т., Zahraa A., Zahraa M. et al. The impact of obesity on seminal fluid in men with infertility // Middle East Fertil. Soc. J. 2018 April 30. URL: https://doi.org/10.1016/j.mefs.2018.04.010/.
8. Alder N.J., Keihani S., Stoddard G.J. et al. Combination therapy with clomiphene citrate + anastrozole is an effective and safe alternative for patients with elevated oestradiol level or low testosterone: oestradiol ratio //. BJU Int. 2018. doi: 10.1111/bju.14390.
9. Awlaqi, A.Al., Alkhayat K., Hammadeh M.E. Metabolic syndrome and infertility in women // Int. J. Womens Health Reprod. Sci. 2016. Vol. 4, N 3. P. 89-95.
10. Bomba-Opon D., Hirnle L., Kalinka J. et al. Folate supplementation during the preconception period, pregnancy and puerperium // Ginekol. Pol. 2017. Vol. 88, N 11. P. 633-636.
11. Broughton D.E., Moley K.H. Obesity and female infertility: potential mediators of obesity's impact // Fertil. Steril. 2017. Vol. 107, N 4. P. 840-847.
12. Cong J., Li P., Zheng L. et al. Prevalence and risk factors of infertility at a rural site of Northern China // PLoS One. 2016. Vol. 11, N 15. URL: https://doi.org/10.1371/journal.pone.0155563.
13. Craig J.R., Jenkins T.G., Carrell D.T. et al. Obesity, male infertility, and the sperm epigenome // Fertil. Steril. 2017. Vol. 107, N 4. P. 848-859.
14. Dargham S.R., Ahmed L., Kilpatrick E.S. et al. The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population // PLoS One. 2017. Vol. 12, N 7. Article ID e0181467. URL: https:// doi.org/10.1371/journal.pone.0181467.
15. Dhandapani K., Kodavanji B., Vinodini N.A. Association of body mass index with primary and secondary infertility among infertile women in Mangalore: a cross-sectional study // Natl J. Physiol. Pharm. Pharmacol. 2016. Vol. 6, N 1. P. 81-84. doi: 10.5455/njppp.2015.5.2108201585.
16. Eisenberg M.L., Lathi R.B., Baker V.L. et al. Frequency of the male infertility evaluation: data from the national survey of family growth // J. Urol. 2013. Vol. 189, N 3. P. 1030-1034.
17. el Bilbeisi A.H., Shab-Bidar S., Jackson D. et al. The prevalence of metabolic syndrome and its related factors among adults in Palestine: a meta-analysis // Ethiop. J. Health Sci. 2017. Vol. 27, N 1. P. 77-84.
18. Fauser B.C., Tarlatzis B.C., Rebar R.W. et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group // Fertil. Steril. 2012. Vol. 97, N 1. P. 28-38.
19. Ferramoscam A., Di Giacomo M., Moscatelli N. et al. Obesity and male infertility: role of fatty acids in the modulation of sperm energetic metabolism // Eur. J. Lipid Sci. Technol. 2018. Vol. 120, N 4. URL: https:// doi.org/10.1002/ejlt.201700451.
20. Global health observatory data repository. Prevalence of obesity among adults, BMI >30, age-standardized. Estimates by WHO region. URL: http://apps.who.int/gho/data/view.main.REGION2480A?lang=en.
21. Global Obesity Levels and Rankings. 2016 URL: https://obesity. procon.org/view.resource.php?resourceID=006032.
22. Hajaratu U.S., Nkeiruka A., Adebiyi G. et al. Evaluation of the infertile male // Afr. J. Infertil. Assist. Concept. 2017. Vol. 1, N 2. P. 27-34.
23. Jalilian A., Kiani F., Sayehmiri F. et al. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: a metaanalysis // Iran. J. Reprod. Med. 2015. Vol. 13, N 10. P. 591604.
24. Kahn B.E., Brannigan R.E. Obesity and male infertility // Curr. Opin. Urol. 2017. Vol. 27, N 5. P. 441-445. doi: 10.1097/MOU.0000000000000417.
25. Kalra B., Kalra S., Sharma J.B. The inositols and polycystic ovary syndrome // Indian J. Endocrinol. Metab. 2016. Vol. 20, N 5. P. 720-724.
26. Klenov V., Jungheim E.S. Obesity and reproductive function: a review of the evidence // Curr. Opin. Obstet. Gynecol. 2014. Vol. 26, N 6. P. 455-460. doi: 10.1097/GCO.0000000000000113.
27. Kort J.D., Winget C., Kim S.H. et al. A retrospective cohort study to evaluate the impact of meaningful weight loss on fertility outcomes in an overweight population with infertility // Fertil. Steril. 2014. Vol. 101, N 5. P. 1400-1403. doi: 10.1016/j.fertnstert.2014.01.036.
28. Kutlu R., Ozberk D.I., Gorkemli H. Incidence of metabolic syndrome and long-term chronic health problems in infertile women // Istanbul Med. J. 2017. Vol. 18. P. 210-217. doi: 10.5152/imj.2017.55823.
29. Legro R.S., Arslanian S.A., Ehrmann D.A. et aL Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline // J. Clin. Endocrinol. Metab. 2014. Vol. 98. P. 4565-4592.
30. MacKenna A., Schwarze J.E., Crosby J.A. et al. Outcome of assisted reproductive technology in overweight and obese women // JBRA Assist. Reprod. 2017. Vol. 2, N 2. P. 79-83. doi: 10.5935/1518-0557.20170020.
31. McCartney C.R., Marshall J.C. Polycystic ovary syndrome // N. Engl. J. Med. 2016. Vol. 375. P. 54-64.
32. Melo A.S., Ferriani R.A., Navarro P.A. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice // Clinics (Sao Paulo). 2015. Vol. 70, N 11. P. 765-769. doi: 10.6061/ clinics/2015(11)09.
33. National Health and Medical Research Council. Iodine supplementation during pregnancy and lactation. Australia, 2010. URL: http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/new45_lit-erature_review.pdf Accessed 10 June 2013.
34. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. London, 2013. URL: www.nice.org.uk/guidance/cg156.
35. Nolan P.B., Carrick-Ranson G., Stinear J.W. et al. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis // Prev. Med. Rep. 2017. Vol. 7. P. 211-215. doi: 10.1016/j.pmedr.2017.07.004.
36. Pan M.D., Hockenberry M.S., Kirby E.W. et al. Male infertility: diagnosis and treatment in the era of in vitro fertilization and intracytoplasmic sperm injection // Med. Clin. North Am. 2018. Vol. 102, N 2. P. 337-347. doi: 10.1016/j.mcna.2017.10.008.
37. Raad G., Hazzouri M., Bottini S. et al. Paternal obesity: how bad is it for sperm quality and progeny health? // Basic Clin. Androl. 2017. Vol. 27. P. 20. doi: 10.1186/s12610-017-0064-9.
38. Rafique M., Nuzrat A. Role of obesity in female infertility and assisted reproductive technology (ART) outcomes // Saudi J. Obes. 2016. Vol. 4, N 2. Р. 76-79.
39. Report: Obesity Rates by Country 2017. URL: https://renewbariat-rics.com/obesity-rank-by-countries/
40. Rittenberg V., Seshadri S., Sunkara S.K. et al. Effect of body mass index on IVF treatment outcome: an updated systematic review and metaanalysis // Reprod. Biomed. Online. 2011. Vol. 23. P. 421-439.
41. Royal College of Obstetricians and Gynaecologists (RCOG). Vitamin D in pregnancy // UK Sci. Impact Paper. 2014. Vol. 43. URL: https:// www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/vitamin_d_sip43_june14.pdf.
42. Sam S., Ehrmann D.A. Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome // Diabeto-logia. 2017. Vol. 60. P. 1656. URL: https://doi.org/10.1007/s00125-017-4306-3.
43. Sermondade N., Faure C., Fezeu L. BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis // Hum. Reprod. Update. 2013. Vol. 19. P. 221-231. doi: 10.1093/humupd/ dms050.
44. South Australian Perinatal Practice Guidelines. Vitamin and mineral supplementation in pregnancy. 2015. 11 p.
45. Suturina L.V., Atalyan A.V., Darzhaev Z.Y. et al. Overweight and obesity prevalence in referral population of infertile women with polycystic ovary syndrome // Adv. Obes. Weight Manag. Control. 2017. Vol. 7, N 1. doi: 10.15406/aowmc.2017.07.00188.
46. Vander M., Wyns B.C. Fertility and Infertility: Definition and Epidemiology. 2018. URL: https://doi.org/10.1016/j.clinbiochem.2018.03.012.
47. Velu A., Prasad G. Epidemiologic aspects of male infertility // Int. J. Reprod. Contracept. Obstet. Gynecol. 2017. Vol. 6, N 8. P. 3362-3365. doi: http://dx.doi.org/10.18203/2320-1770.ijrcog20173446.
48. Vuong L.N., Dang V.Q., Tuong M.Ho. et al. IVF transfer of fresh or frozen embryos in women without polycystic ovaries // N. Engl. J. Med. 2018. Vol. 378. P. 137-147. doi: 10.1056/NEJMoa1703768.
49. World Health Organization. Obesity and overweight. Geneva : WHO. URL: http://www.who.int/mediacentre/factsheets/fs311/en
References
1. Vityazeva I.I., Altashina M.V., Troshina E.A. Influence of fat metabolism disorders on the fertility of men of reproductive age and the effectiveness of IVF programs Problemy endokrinologii [Problems of Endocrinology]. 2014; 60 (5): 34-42. (in Russian)
2. World Health Organization (WHO). Fact sheet: Obesity and overweight. October 18, 2017: URL: http://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight. (in Russian)
3. Dolgushina N.V., Desyatkova N.V., Korotchenko O.E., et al. Influence of overweight and obesity on the development of aneuploidy of embryos and outcomes of programs of assisted reproductive technologies. Problemy reproduktsii [Problems of Reproduction]. 2017; 23 (1): 48-53. (in Russian)
4. Koloda Yu.A. Features of assisted reproductive technologies in patients with overweight and obesity: Autoabstract of Diss. Moscow, 2010: 117 p. (in Russian).
5. Interdisciplinary Association of Specialists in Reproductive Medicine (MARS). Pre-course preparation. Clinical protocol for specialists in the field of reproductive medicine. Moscow: StatusPraesens, 2016: 86 p. (in Russian)
6. Makhmadalieva M.R., Kogan I.Yu., Niaouri D.A. The effect of excess body weight and obesity on the effectiveness of assisted reproductive technology programs. Zhurnal akusherstva i zhenskikh bolezney [Journal of Obstetrics and Female Diseases]. 2018; 67 (2): 32-9. doi: 10.17816/ JOWD67232-39. (in Russian)
7. Alahmar A.T., Zahraa A., Zahraa M., et al. The impact of obesity on seminal fluid in men with infertility. Middle East Fertil Soc. J. 2018 April 30. URL: https://doi.org/10.1016/j.mefs.2018.04.010/.
8. Alder N.J., Keihani S., Stoddard G.J., et al. Combination therapy with clomiphene citrate + anastrozole is an effective and safe alternative for patients with elevated oestradiol level or low testosterone: oestradiol ratio. BJU Int. 2018. doi: 10.1111/bju.14390.
9. Awlaqi, A.Al., Alkhayat K., Hammadeh M.E. Metabolic syndrome and infertility in women. Int J Womens Health Reprod. Sci. 2016; 4 (3): 89-95.
10. Bomba-Opon D., Hirnle L., Kalinka J., et al. Folate supplementation during the preconception period, pregnancy and puerperium. Ginekol Pol. 2017; 88 (11): 633-6.
11. Broughton D.E., Moley K.H. Obesity and female infertility: potential mediators of obesity's impact. Fertil Steril. 2017; 107 (4): 840-7.
12. Cong J., Li P., Zheng L., et al. Prevalence and risk factors of infertility at a rural site of Northern China. PLoS One. 2016; 11 (15). URL: https://doi.org/10.1371/journal.pone.0155563.
13. Craig J.R., Jenkins T.G., Carrell D.T., et al. Obesity, male infertility, and the sperm epigenome. Fertil Steril. 2017; 107 (4): 848-59.
14. Dargham S.R., Ahmed L., Kilpatrick E.S., et aL The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population. PLoS One. 2017; 12 (7): e0181467. URL: https://doi.org/10.1371/ journaLpone.0181467.
15. Dhandapani K., Kodavanji B., Vinodini N.A. Association of body mass index with primary and secondary infertility among infertile women in Mangalore: a cross-sectional study. Natl J Physiol Pharm Pharmacol. 2016; 6 (1): 81-4. doi: 10.5455/njppp.2015.5.2108201585.
16. Eisenberg M.L., Lathi R.B., Baker V.L., et aL Frequency of the male infertility evaluation: data from the national survey of family growth. J Urol. 2013; 189 (3): 1030-4.
17. el BiLbeisi A.H., Shab-Bidar S., Jackson D., et aL The prevalence of metabolic syndrome and its related factors among adults in Palestine: a meta-anaLysis. Ethiop J Health Sci. 2017; 27 (1): 77-84.
18. Fauser B.C., TarLatzis B.C., Rebar R.W., et aL. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. FertiL SteriL. 2012; 97 (1): 28-38.
19. Ferramoscam A., Di Giacomo M., MoscateLLi N., et aL. Obesity and maLe infertiLity: roLe of fatty acids in the moduLation of sperm energetic metaboLism. Eur J Lipid Sci TechnoL. 2018; 120 (4). URL: https:// doi.org/10.1002/ejLt.201700451.
20. GLobaL heaLth observatory data repository. PrevaLence of obesity among aduLts, BMI >30, age-standardized. Estimates by WHO region. URL: http://apps.who.int/gho/data/view.main.REGION2480A?Lang=en.
21. GLobaL Obesity LeveLs and Rankings. 2016 URL: https://obesity. procon.org/view.resource.php?resourceID=006032.
22. Hajaratu U.S., Nkeiruka A., Adebiyi G., et aL. EvaLuation of the infertiLe maLe. Afr J InfertiL Assist Concept. 2017; 1 (2): 27-34.
23. JaLiLian A., Kiani F., Sayehmiri F., et aL. PrevaLence of poLycystic ovary syndrome and its associated compLications in Iranian women: a metaanaLysis. Iran J Reprod Med. 2015; 13 (10): 591-604.
24. Kahn B.E., Brannigan R.E. Obesity and maLe infertiLity. Curr Opin UroL. 2017; 27 (5): 441-5. doi: 10.1097/MOU.0000000000000417.
25. KaLra B., KaLra S., Sharma J.B. The inositoLs and poLycystic ovary syndrome. Indian J EndocrinoL Metab. 2016; 20 (5): 720-4.
26. KLenov V., Jungheim E.S. Obesity and reproductive function: a review of the evidence. Curr Opin Obstet GynecoL. 2014; 26 (6): 455-60. doi: 10.1097/GCO.0000000000000113.
27. Kort J.D., Winget C., Kim S.H., et aL. A retrospective cohort study to evaLuate the impact of meaningfuL weight Loss on fertiLity outcomes in an overweight popuLation with infertiLity. FertiL SteriL. 2014; 101 (5): 1400-3. doi: 10.1016/j.fertnstert.2014.01.036.
28. KutLu R., Ozberk D.I., GorkemLi H. Incidence of metaboLic syndrome and Long-term chronic heaLth probLems in infertiLe women. IstanbuL Med J. 2017; 18: 210-7. doi: 10.5152/imj.2017.55823.
29. Legro R.S., ArsLanian S.A., Ehrmann D.A., et aL. Diagnosis and treatment of poLycystic ovary syndrome: an Endocrine Society cLinicaL practice guideLine. J CLin EndocrinoL Metab. 2014; 98: 4565-92.
30. MacKenna A., Schwarze J.E., Crosby J.A., et aL. Outcome of assisted reproductive technoLogy in overweight and obese women. JBRA Assist Re-prod. 2017; 2 (2): 79-83. doi: 10.5935/1518-0557.20170020.
31. McCartney C.R., MarshaLL J.C. PoLycystic ovary syndrome. N EngL J Med. 2016; 375: 54-64.
32. MeLo A.S., Ferriani R.A., Navarro P.A. Treatment of infertiLity in women with poLycystic ovary syndrome: approach to cLinicaL practice. CLinics (Sao PauLo). 2015; 70 (11): 765-9. doi: 10.6061/cLinics/2015(11)09.
33. NationaL HeaLth and MedicaL Research CounciL. Iodine suppLementation during pregnancy and Lactation. AustraLia, 2010. URL: http:// www.nhmrc.gov.au/_fiLes_nhmrc/pubLications/attachments/new45_Lit-erature_review.pdf Accessed 10 June 2013.
34. NationaL Institute for HeaLth and Care ExceLLence. FertiLity probLems: assessment and treatment. London, 2013. URL: www.nice.org.uk/guidance/cg156.
35. NoLan P.B., Carrick-Ranson G., Stinear J.W., et aL. PrevaLence of metaboLic syndrome and metaboLic syndrome components in young aduLts: a pooLed anaLysis. Prev Med Rep. 2017; 7: 211-5. doi: 10.1016/ j.pmedr.2017.07.004.
36. Pan M.D., Hockenberry M.S., Kirby E.W., et aL. MaLe infertiLity: diagnosis and treatment in the era of in vitro fertiLization and intracytopLasmic sperm injection. Med CLin North Am. 2018; 102 (2): 337-47. doi: 10.1016/j.mcna.2017.10.008.
37. Raad G., Hazzouri M., Bottini S., et aL. PaternaL obesity: how bad is it for sperm quaLity and progeny heaLth? Basic CLin AndroL. 2017; 27: 20. doi: 10.1186/s12610-017-0064-9.
38. Rafique M., Nuzrat A. RoLe of obesity in femaLe infertiLity and assisted reproductive technoLogy (ART) outcomes. Saudi J Obes. 2016; 4 (2): 76-9.
39. Report: Obesity Rates by Country 2017. URL: https://renewbariat-rics.com/obesity-rank-by-countries/
40. Rittenberg V., Seshadri S., Sunkara S.K., et aL. Effect of body mass index on IVF treatment outcome: an updated systematic review and metaanaLysis. Reprod Biomed OnLine. 2011; 23: 421-39.
41. RoyaL CoLLege of Obstetricians and GynaecoLogists (RCOG). Vitamin D in pregnancy. UK Sci Impact Paper. 2014; 43. URL: https://www.rcog.org.uk/gLobaLassets/documents/guideLines/scientific-impact-papers/vitamin_d_sip43_june14.pdf.
42. Sam S., Ehrmann D.A. Metformin therapy for the reproductive and metaboLic consequences of poLycystic ovary syndrome. DiabetoLogia. 2017; 60: 1656. URL: https://doi.org/10.1007/s00125-017-4306-3.
43. Sermondade N., Faure C., Fezeu L. BMI in reLation to sperm count: an updated systematic review and coLLaborative meta-anaLysis. Hum Re-prod Update. 2013; 19: 221-31. doi: 10.1093/humupd/ dms050.
44. South AustraLian PerinataL Practice GuideLines. Vitamin and mineraL suppLementation in pregnancy. 2015: 11 p.
45. Suturina L.V., AtaLyan A.V., Darzhaev Z.Y., et aL. Overweight and obesity prevaLence in referraL popuLation of infertiLe women with poLycystic ovary syndrome. Adv Obes Weight Manag ControL. 2017; 7 (1). doi: 10.15406/aowmc.2017.07.00188.
46. Vander M., Wyns B.C. FertiLity and infertiLity: definition and epidemioLogy. 2018. URL: https://doi.org/10.1016/j.cLinbiochem.2018.03.012.
47. VeLu A., Prasad G. EpidemioLogic aspects of maLe infertiLity. Int J Reprod Contracept Obstet GynecoL. 2017; 6 (8) : 3362-5. doi: http:// dx.doi.org/10.18203/2320-1770.ijrcog20173446.
48. Vuong L.N., Dang V.Q., Tuong M.Ho., et aL. IVF transfer of fresh or frozen embryos in women without poLycystic ovaries. N EngL J Med. 2018; 378: 137-47. doi: 10.1056/NEJMoa1703768.
49. WorLd HeaLth Organization. Obesity and overweight. Geneva: WHO. URL: http://www.who.int/mediacentre/factsheets/fs311/en